Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Tuncay Göskel"'
Autor:
Jonathan W. Goldman, Julien Mazieres, Fabrice Barlesi, Konstantin H. Dragnev, Marianna Koczywas, Tuncay Göskel, Alexis B. Cortot, Nicolas Girard, Claas Wesseler, Helge Bischoff, Ernest Nadal, Keunchil Park, Shun Lu, Alvaro Taus, Manuel Cobo, Shawn T. Estrem, Sameera R. Wijayawardana, Kellie Turner, Gerard Joseph Oakley, Karla C. Hurt, Alan Y. Chiang, Anwar M. Hossain, William J. John, Luis Paz-Ares
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
IntroductionJUNIPER compared the efficacy and safety of abemaciclib, a selective cyclin-dependent kinase 4 and 6 inhibitor, with erlotinib in patients with non-small cell lung cancer (NSCLC) harboring a Kirsten rat sarcoma (KRAS) mutation.MethodsJUNI
Externí odkaz:
https://doaj.org/article/4c938db73a4443b18e2317f0a0f304fd
Autor:
Tuncay Göskel, Alan Y. Chiang, Fabrice Barlesi, Shun Lu, Gerard J. Oakley, Alexis B. Cortot, Helge Bischoff, Álvaro Taus, Keunchil Park, Jonathan W. Goldman, Nicolas Girard, C. Wesseler, Sameera R. Wijayawardana, Kellie Turner, Shawn T. Estrem, Ernest Nadal, Karla Hurt, Luis Paz-Ares, William J. John, Konstantin H. Dragnev, Manuel Cobo, Julien Mazieres, Marianna Koczywas, Anwar Hossain
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Introduction JUNIPER compared the efficacy and safety of abemaciclib, a selective cyclin-dependent kinase 4 and 6 inhibitor, with erlotinib in patients with non-small cell lung cancer (NSCLC) harboring a Kirsten rat sarcoma (KRAS) mutation. Methods J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8102b42793bed505aef10f7c7c22be12
https://hdl.handle.net/11454/61824
https://hdl.handle.net/11454/61824
